Global Wealth Strategies & Associates’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7
Closed -$2.05K 197
2026
Q1
$2.05K Hold
7
﹤0.01% 416
2025
Q4
$2.45K Hold
7
﹤0.01% 410
2025
Q3
$2.26K Hold
7
﹤0.01% 384
2025
Q2
$2.72K Hold
7
﹤0.01% 295
2025
Q1
$3.04K Hold
7
﹤0.01% 355
2024
Q4
$2.58K Hold
7
﹤0.01% 307
2024
Q3
$3.64K Hold
7
﹤0.01% 258
2024
Q2
$3.79K Hold
7
﹤0.01% 235
2024
Q1
$3.63K Hold
7
﹤0.01% 241
2023
Q4
$3.3K Hold
7
﹤0.01% 227
2023
Q3
$3.05K Hold
7
﹤0.01% 232
2023
Q2
$3.11K Hold
7
﹤0.01% 229
2023
Q1
$3.22K Hold
7
﹤0.01% 237
2022
Q4
$3.59K Buy
+7
New +$3.55K ﹤0.01% 234

Other funds holding ELV

Global Wealth Strategies & Associates's ELV Position: Q2 2026 in Review

Global Wealth Strategies & Associates sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 7 shares — an estimated $2.05K sold.

Global Wealth Strategies & Associates first reported a position in ELV in Q4 2022 and held it in 14 quarters. The position peaked at $3.79K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Global Wealth Strategies & Associates reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 7 Elevance Health shares in Q2 2026, an estimated $2.05K.
  • Global Wealth Strategies & Associates first reported a position in Elevance Health in Q4 2022 and held it in 14 quarters.
  • Global Wealth Strategies & Associates's Elevance Health position peaked at $3.79K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.